- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04440241
Regenerative Surgical Treatment of Peri-implant Defects
Regenerative Surgical Treatment of Peri-implant Defects. Submerged Versus Not Submerged
Does submerged healing of implants improve clinical and radiologic outcomes for the treatment of peri-implantitis? A number of recent systematic reviews have shown that the prevalence of periimplantitisin the population is high.
Nevertheless, there appears to be no consensus on treatment standards for the management of peri-implant diseases. Also, the significant variation in the empirical use of the available therapeutic modalities seems to result in moderately effective treatment outcomes. Animal and human case series-studies have shown improved outcomes when using a submerged healing approach. However, there seems to be no randomized controlled clinical studies comparing submerged/non-submerged healing efficacy for the treatment of peri-implantitis. Since current modalities for the treatment of peri-implantitis seem to result inmoderately effective outcomes, there is an urgency to investigate treatment strategies that will result in improved patient's benefits in terms of health.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The present study will be double-blinded randomized controlled clinical trial. Patients requiring surgical treatment of peri-implantitis after non-surgical therapy will beassigned to either:
Test group: submerged healing or Control group: non-submerged healing treatment of peri-implantitis using guided bone regeneration with a bone substitute and a resorbable membrane.
The primary aim of this study is to evaluate whether submerged healing of implants willsignificantly improve the changes in marginal bone levels measured on X-rays 12months post-treatment compared to a non-submerged healing approach for the treatment of peri-implantitis.
Secondary aims include changes in clinical attachment levels, changes in probing pocket depth, recession, keratinized tissue, occurrence of bleeding on probing, suppuration on probing (PUS), marginal gingival recession (REC), full mouth plaque score (FMPS), full mouth bleeding score (FMBS), type of peri-implant bone defect, frequency and type of complications and implant loss.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Santiago Mareque
- Phone Number: 616 975 256
- Email: smareque@gmail.com
Study Contact Backup
- Name: Juan Blanco
- Phone Number: 616 975 256
- Email: smareque@gmail.com
Study Locations
-
-
A Coruña
-
Santiago De Compostela, A Coruña, Spain, 15782
- Recruiting
- Master Periodoncia. Facultad odontología
-
Contact:
- Santiago Mareque
- Email: smareque@gmail.com
-
Contact:
- Carlota Blanco
- Email: carlota.blanco@rai.usc.es
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥18 years.
- Systemically healthy patients.
- Presence of at least 1 implant diagnosed with peri-implantitis (peri-implant probing pocket depth ≥6 mm in at least 1 aspect of the implant with bleeding and/or suppuration on probing and radiographically documented marginal bone loss ≥3mm) according to Renvert et al. (2018), after non-surgical therapy of periimplantitis, and a 4mm deep intrabony component.
- Absence of mobility of the implants.
- Individual implant-supported crown or partial fixed implant supported restoration (removable prosthesis will be excluded).
- Patient's smoking ≤ 10 cigarettes/day.
Exclusion Criteria:
- Non-removable prostheses
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Test group
submerged healing treatment of peri-implantitis using guided bone regeneration with a bone substitute and a resorbable membrane.
|
Full thickness buccal and lingual flaps will be performed. After debridement of the defect using hand and ultrasonic instruments and implant surface decontamination using titanium brushes (TiBrush®) and saline Regenerative treatment will be performed only in the intrabony component of type 1 peri-implant defects. Guided bone regeneration using a bone substitute (Bio-oss®) and a resorbable membrane (bio-gide®) will be performed in the intrabony and dehiscenses areas of the defect. The surgeon will be blinded to the assignment of treatment until it is time to close the flaps. |
EXPERIMENTAL: Control group
non submerged healing treatment of peri-implantitis using guided bone regeneration with a bone substitute and a resorbable membrane.
|
Full thickness buccal and lingual flaps will be performed. After debridement of the defect using hand and ultrasonic instruments and implant surface decontamination using titanium brushes (TiBrush®) and saline Regenerative treatment will be performed only in the intrabony component of type 1 peri-implant defects. Guided bone regeneration using a bone substitute (Bio-oss®) and a resorbable membrane (bio-gide®) will be performed in the intrabony and dehiscenses areas of the defect. The surgeon will be blinded to the assignment of treatment until it is time to close the flaps. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes marginal bone level
Time Frame: baseline, 6 and 12 months
|
measured on periapical X-rays, from the shoulder of the implant to the bottom of the bone defect next to the implant at the mesial and distal surfaces.
Mean marginal bone levels between mesial and distal measurements will be calculated.
|
baseline, 6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes Probing pocket depth
Time Frame: baseline, 6 and 12 months
|
distance from the margin gingival to the bottom of the peri-implant pouch.
All clinical variables will be recorded with a Hu-friedy CP15 UNC millimeter probe in six points on each implant.
|
baseline, 6 and 12 months
|
Changes Clinical attachment level
Time Frame: baseline, 6 and 12 months
|
Distance from the implant shoulder or prosthetic abutment to the bottom of the peri-implant pocket.
|
baseline, 6 and 12 months
|
Change Reccesion
Time Frame: baseline, 6 and 12 months
|
distance from the margin of the peri-implant mucosa to the implant / abutment interface.
|
baseline, 6 and 12 months
|
Change Keratinized mucosa
Time Frame: baseline, 6 and 12 months
|
distance from the gingival margin up to the mucogingival line.
|
baseline, 6 and 12 months
|
Change blending on probing
Time Frame: baseline, 6 and 12 months
|
Registry of presence of bleeding by binary scale (1 bleed present / 0 bleed absent)
|
baseline, 6 and 12 months
|
Change supuration
Time Frame: baseline, 6 and 12 months
|
Pus presence register by scale binary (1 present / 0 absent)
|
baseline, 6 and 12 months
|
Change plaque score
Time Frame: baseline, 6 and 12 months
|
Registration of presence of plaque by binary scale on each surface (1 present / 0 absent), calculating the percentage of total surfaces in which plaque is detected by using a periodontal probe
|
baseline, 6 and 12 months
|
configuration of the bone defect
Time Frame: baseline
|
Based on the classification of Schwarz et al. (2007)
|
baseline
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Santiago Mareque, University of Santiago de Compostela
Publications and helpful links
General Publications
- Schwarz F, Herten M, Sager M, Bieling K, Sculean A, Becker J. Comparison of naturally occurring and ligature-induced peri-implantitis bone defects in humans and dogs. Clin Oral Implants Res. 2007 Apr;18(2):161-70. doi: 10.1111/j.1600-0501.2006.01320.x. Erratum In: Clin Oral Implants Res. 2007 Jun;18(3):397.
- Schwarz F, Sahm N, Schwarz K, Becker J. Impact of defect configuration on the clinical outcome following surgical regenerative therapy of peri-implantitis. J Clin Periodontol. 2010 May;37(5):449-55. doi: 10.1111/j.1600-051X.2010.01540.x. Epub 2010 Mar 24.
- Roccuzzo M, Bonino F, Bonino L, Dalmasso P. Surgical therapy of peri-implantitis lesions by means of a bovine-derived xenograft: comparative results of a prospective study on two different implant surfaces. J Clin Periodontol. 2011 Aug;38(8):738-45. doi: 10.1111/j.1600-051X.2011.01742.x. Epub 2011 Jun 2.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REGT_CT_19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implant Site Pocket Infection
-
Mikkel HerlyOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsRecruitingAntibiotic Side Effect | Implant Complication | Implant Site Infection | Implant Infection | Implant Capsular Contracture | Implant Site Pocket Infection | Implant ExpulsionDenmark
-
Eskisehir Osmangazi UniversityCompleted
-
McGill UniversityMcGill University Health Centre/Research Institute of the McGill University...Enrolling by invitationHypersensitivity | Peri-Implantitis | Peri-implant Mucositis | Implant Site Reaction | Implant Site Infection | Implant Infection | Implant Site RashCanada
-
Institute of Cardiology, Warsaw, PolandUnknownFever of Unknown Origin | Infective Endocarditis | Complications | Implant Site Pocket InfectionPoland
-
Cairo UniversityBioHorizons, Inc.CompletedImplant Site InfectionEgypt
-
LeadExx Cardiac Ltd.UnknownImplant Site Infection
-
Universitätsmedizin MannheimCompletedImplant Complication | Complication, Postoperative | Implant Site Infection
-
National Research Centre, EgyptCompletedImplant Complication | Implant Site ReactionEgypt
-
Seoul National University HospitalActive, not recruitingBreast Implant Infection
-
Cairo UniversityNot yet recruitingDental Implant Failed | Implant Site Reaction
Clinical Trials on regenerative treatment periimplantitis
-
Postgraduate Institute of Dental Sciences RohtakActive, not recruiting
-
Istanbul UniversityAbant Izzet Baysal University; Istanbul Kent UniversityCompletedApexification | Regenerative Endodontic | FractalsTurkey
-
Mansoura UniversityCompletedNecrotic Pulp | Regenerative Endodontic ProceduresEgypt
-
University Hospital, MontpellierUniversity of BarcelonaCompleted
-
Sanford HealthActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
Azienda Ospedaliero-Universitaria di ModenaUniversity of Modena and Reggio Emilia; The European Research Group on Periodontology... and other collaboratorsActive, not recruiting
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)CompletedPost-Mastectomy Chronic Pain SyndromeUnited States
-
Alexandria UniversityCompletedNecrotic Pulp | Periapical; InfectionEgypt
-
Luis MonteiroRecruitingPeri-ImplantitisPortugal
-
Medical University of WarsawRecruitingPeriodontitis | RegenerationPoland